Big Gain For Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc. (ARMP:NYSEMKT) shot up at $1.57, a gain of 36.5%. On Mon, Jul 24, 2023, ARMP:NYSEMKT touched a New 2-Week High of $1.57. From Mon, Jul 10, 2023, the stock recorded 60.00% Up Days and 18.18% Green Days

About Armata Pharmaceuticals Inc. (ARMP:NYSEMKT)

Ampliphi Biosciences Corp is a clinical-stage biotechnology company focused on the development of bacteriophage-based therapies for the treatment of antibiotic-resistant bacterial infections. The company is developing phage product candidates using a proprietary discovery and development platform, which is designed for rapid identification, characterization, and manufacturing of multiple phage therapeutics. The lead product candidates are AB-SA01 for the treatment of Staphylococcus aureus infections; and AB-PA01 for the treatment of Paeruginosa infections.